Antibodies to oxidised LDL

被引:50
作者
Vaarala, O [1 ]
机构
[1] Natl Publ Hlth Inst, Dept Biochem, SF-00300 Helsinki, Finland
关键词
oxidised LDL; cardiolipin; atherosclerosis; antiphospholipid syndrome; SLE;
D O I
10.1191/096120300678828280
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In prospective studies antibodies to oxidised LDL (low density lipoprotein) have been shown to predict myocardial infarction and progression of carotid athesclerosis in non-autoimmune subjects. The antibodies to oxidised LDL are crossreactive with antiphospholipid antibodies most likely due to their binding to oxidised phospholipids. The Frequent occurrence of these antibodies and their association with arterial thrombosis in patients with SLE and antiphospholipid syndrome suggest their involvement in the development of accelerated atherosclerosis in these patients. Some in vitro studies suggest that antibodies to oxidised LDL may have an atherogenic effect by enhancing the lipid accumulation into macrophages in the atherosclerotic vessels. These antibodies can be considered as markers of the pathogenic determinants of atherosclerosis, such as enhanced lipid oxidation, proinflammatory stage and impaired vasodilatation.
引用
收藏
页码:202 / 205
页数:4
相关论文
共 36 条
[1]  
Aho K, 1996, CLIN EXP RHEUMATOL, V14, P499
[2]  
Amengual O, 1997, BRIT J RHEUMATOL, V36, P964
[3]  
Ames PRJ, 1998, THROMB HAEMOSTASIS, V79, P447
[4]   Antiphospholipid, anti-β2-glycoprotein-I and anti-oxidized-low-density-lipoprotein antibodies in antiphospholipid syndrome [J].
Cuadrado, MJ ;
Tinahones, F ;
Camps, MT ;
De Ramon, E ;
Gómez-Zumaquero, JM ;
Mujic, F ;
Khamashta, MA ;
Hughes, GRV .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 1998, 91 (09) :619-626
[5]   Increased levels of autoantibodies to cardiolipin and oxidised low density lipoprotein are inversely associated with plasma vitamin C status in cigarette smokers [J].
Fickl, H ;
VanAntwerpen, VL ;
Richards, GA ;
VanderWesthuyzen, DR ;
Davies, N ;
VanderWalt, R ;
VanderMerwe, CA ;
Anderson, R .
ATHEROSCLEROSIS, 1996, 124 (01) :75-81
[6]   Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes [J].
Freigang, S ;
Hörkkö, S ;
Miller, E ;
Witztum, JL ;
Palinski, W .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (12) :1972-1982
[7]   Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis [J].
George, J ;
Afek, A ;
Gilburd, B ;
Levkovitz, H ;
Shaish, A ;
Goldberg, I ;
Kopolovic, Y ;
Wick, G ;
Shoenfeld, Y ;
Harats, D .
ATHEROSCLEROSIS, 1998, 138 (01) :147-152
[8]   Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with β2-glycoprotein I [J].
George, J ;
Afek, A ;
Gilburd, B ;
Blank, M ;
Levy, Y ;
Aron-Maor, A ;
Levkovitz, H ;
Shaish, A ;
Goldberg, I ;
Kopolovic, J ;
Harats, D ;
Shoenfeld, Y .
CIRCULATION, 1998, 98 (11) :1108-1115
[9]   Involvement of beta(2)-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages [J].
Hasunuma, Y ;
Matsuura, E ;
Makita, Z ;
Katahira, T ;
Nishi, S ;
Koike, T .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 107 (03) :569-573
[10]   Presence of hypochlorite-modified proteins in human atherosclerotic lesions [J].
Hazell, LJ ;
Arnold, L ;
Flowers, D ;
Waeg, G ;
Malle, E ;
Stocker, R .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (06) :1535-1544